These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 10936811)

  • 1. Pathophysiology of cardiovascular disease in hemodialysis patients.
    Meeus F; Kourilsky O; Guerin AP; Gaudry C; Marchais SJ; London GM
    Kidney Int Suppl; 2000 Aug; 76():S140-7. PubMed ID: 10936811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathophysiology of left ventricular hypertrophy in dialysis patients.
    London GM; Guerin AP; Marchais SJ
    Blood Purif; 1994; 12(4-5):277-83. PubMed ID: 7865187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations of arterial function in end-stage renal disease.
    London GM
    Nephron; 2000 Feb; 84(2):111-8. PubMed ID: 10657710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intensive Hemodialysis, Left Ventricular Hypertrophy, and Cardiovascular Disease.
    McCullough PA; Chan CT; Weinhandl ED; Burkart JM; Bakris GL
    Am J Kidney Dis; 2016 Nov; 68(5S1):S5-S14. PubMed ID: 27772643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac hypertrophy and arterial alterations in end-stage renal disease: hemodynamic factors.
    London GM; Marchais SJ; Guerin AP; Metivier F; Pannier B
    Kidney Int Suppl; 1993 Jun; 41():S42-9. PubMed ID: 8320946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular disease in chronic renal failure: pathophysiologic aspects.
    London GM
    Semin Dial; 2003; 16(2):85-94. PubMed ID: 12641870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular disease and atherosclerosis in uremia.
    London GM
    Nefrologia; 2005; 25 Suppl 2():91-5. PubMed ID: 16050410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathophysiology of anaemia: focus on the heart and blood vessels.
    Metivier F; Marchais SJ; Guerin AP; Pannier B; London GM
    Nephrol Dial Transplant; 2000; 15 Suppl 3():14-8. PubMed ID: 11032352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cardiac anomalies in chronic renal failure].
    Guérin A; Marchais S; Pannier B; London G
    Presse Med; 2000 Feb; 29(5):274-80. PubMed ID: 10701411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contributive factors to cardiovascular hypertrophy in renal failure.
    London GM; Marchais SJ; Guerin AP; Métivier F
    Am J Hypertens; 1989 Nov; 2(11 Pt 2):261S-263S. PubMed ID: 2530994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Left ventricular hypertrophy in patients on hemodialysis: importance of anemia].
    Stojimirović B; Petrović D; Obrenović R
    Med Pregl; 2007; 60 Suppl 2():155-9. PubMed ID: 18928184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular disease in renal failure.
    Guerin AP; Adda H; London GM; Marchais SJ
    Minerva Urol Nefrol; 2004 Sep; 56(3):279-88. PubMed ID: 15467506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is regression of left ventricular hypertrophy in maintenance hemodialysis patients possible?
    Bossola M; Tazza L; Vulpio C; Luciani G
    Semin Dial; 2008; 21(5):422-30. PubMed ID: 18764802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regression of left ventricular hypertrophy in hemodialysis patients is possible.
    Hampl H; Sternberg C; Berweck S; Lange D; Lorenz F; Pohle C; Riedel E; Gogoll L; Hennig L
    Clin Nephrol; 2002 Jul; 58 Suppl 1():S73-96. PubMed ID: 12227731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diastolic dysfunction in chronic renal failure patients under hemodialysis].
    Douchet MP; Couppie P; Chantrel F; Kuntz C; Hannedouche T
    Ann Cardiol Angeiol (Paris); 1996 Dec; 45(10):589-92. PubMed ID: 9033698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular calcifications in uremic patients: clinical impact on cardiovascular function.
    London GM
    J Am Soc Nephrol; 2003 Sep; 14(9 Suppl 4):S305-9. PubMed ID: 12939386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac mortality prevention in uremic patients. Therapeutic strategies with particular attention to complete correction of renal anemia.
    Berweck S; Hennig L; Sternberg C; Dingerkus H; Ludat K; Hampl H
    Clin Nephrol; 2000 Feb; 53(1 Suppl):S80-5. PubMed ID: 10746811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Should the preservation of residual renal function cost volume overload and its consequence left ventricular hypertrophy in new hemodialysis patients?
    Gunal AI; Kirciman E; Guler M; Yavuzkir M; Celiker H
    Ren Fail; 2004 Jul; 26(4):405-9. PubMed ID: 15462109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wave reflections and cardiac hypertrophy in chronic uremia. Influence of body size.
    Marchais SJ; Guerin AP; Pannier BM; Levy BI; Safar ME; London GM
    Hypertension; 1993 Dec; 22(6):876-83. PubMed ID: 8244520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arterial structural and functional alterations in uraemia.
    Guérin AP; Marchais SJ; Metivier F; London GM
    Eur J Clin Invest; 2005 Dec; 35 Suppl 3():85-8. PubMed ID: 16281963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.